Study Stopped
The study team is preparing the materials for the next phase of the study.
Weight Management After Cancer for Survivors in Rural Communities
WeCan-Rural
Development and Pilot Testing of a Novel Intervention to Reduce Cardiovascular Disease Risk Among Breast Cancer Survivors Living in Rural, Medically Underserved Communities
1 other identifier
interventional
40
1 country
3
Brief Summary
This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, staying active, and managing their weight. These changes may help lower the risk of heart disease after cancer treatment. The study will answer two main questions:
- Can study team successfully recruit and keep participants in the study, and will the participants find the program helpful and easy to follow?
- Will participants who join the program see better results in areas like weight, symptoms, diet, physical activity, and confidence in managing the participant's health compared to those who receive standard care? Here's what participants will do:
- Visit the participant's clinic twice (about 12 weeks apart) to be weighed, have the blood pressure checked, give a blood sample, and complete a short walking test
- Fill out online surveys about the participant's health, diet, physical activity, symptoms, and confidence in managing the participant's health
- Be randomly assigned (like flipping a coin) to either receive the WeCan-Rural program or standard health information
- If assigned to the program, attend 12 weekly one-hour video sessions on Zoom with a trained therapist
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2026
CompletedFirst Submitted
Initial submission to the registry
February 17, 2026
CompletedFirst Posted
Study publicly available on registry
February 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 19, 2026
February 1, 2026
12 months
February 17, 2026
May 15, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Satisfaction with Treatment and Interventionist as measured by the Satisfaction with Therapy and Therapist Scale-Revised (STTS-R)
Participants will complete the 13-item Satisfaction with Therapy and Therapist Scale-Revised specific to the program they received. The first 12 items ask participants to rate their agreement with statements related to intervention satisfaction on a 5-point scale ranging from "strongly disagree" (1) to "strongly agree" (5). The 13th item asks "How much did the intervention help with your symptoms?" with 5 answer choices ranging from "made things a lot better" to "made things a lot worse."
Post-treatment (about 12-14 weeks after baseline)
Acceptability as measured by the Treatment Acceptability Questionnaire
The Treatment Acceptability Questionnaire is a six-item scale assessing participants' views of an intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable") and averaged.
Post-treatment (about 12-14 weeks after baseline)
Secondary Outcomes (19)
Change in blood pressure (systolic and diastolic)
From Baseline to Post-treatment (about 12-14 weeks after baseline)
Change in weight
From Baseline to Post-treatment (about 12-14 weeks after baseline)
Change in total cholesterol
From Baseline to Post-treatment (about 12-14 weeks after baseline)
Change in LDL cholesterol
From Baseline to Post-treatment (about 12-14 weeks after baseline)
Change in HDL cholesterol
From Baseline to Post-treatment (about 12-14 weeks after baseline)
- +14 more secondary outcomes
Other Outcomes (3)
Food environment as measured by the Perceived Nutrition Environment Measure
Baseline
Assessment of rurality as measured by selected items from the Rural Active Living Perceived Support Scale
Baseline
Health literacy as measured by Medical Term Recognition Test (METER)
Baseline
Study Arms (2)
WeCan-Rural
EXPERIMENTALParticipants will receive the WeCan-Rural intervention, which includes twelve sessions delivered remotely (i.e., videoconferencing) by a trained therapist.
Control
NO INTERVENTIONParticipants will receive the National Cancer Institute-developed booklet "Facing Forward: Life After Cancer Treatment," which presents information about cancer survivorship topics.
Interventions
The WeCan-Rural program includes 12, one-hour weekly sessions via Zoom that help breast cancer survivors manage symptoms like pain, fatigue, and emotional distress, while also building healthy habits around eating, exercise, and weight management.
Eligibility Criteria
You may qualify if:
- aged 18 years or older
- female (biological sex)
- diagnosis of stage I-III breast cancer
- completed treatments with curative intent (with the exception of hormonal treatments) in the last 5 years
- body mass index \>30
- healthy enough to participate in home-based physical activity
- able to speak/read English
- reports rating of ≥4 (i.e., moderate or more severe) out of 10 for one or more of the following symptoms at its worst in the last month (per the MD Anderson Symptom Inventory): pain, fatigue, sadness, and/or distress
You may not qualify if:
- visual, hearing or cognitive impairment or severe mental illness interfering with participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (3)
Maria Parham Cancer Center
Henderson, North Carolina, 27536, United States
Scotland Health
Laurinburg, North Carolina, 28352, United States
UNC Health Southeastern
Lumberton, North Carolina, 28358, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline Dorfman, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2026
First Posted
February 23, 2026
Study Start
January 13, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share